Professional Advisory Services’s AstraZeneca AZN Stock Holding History

Professional Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.2M	Buy	+161,624	New	+$30.4M	3.62%	7
2026 Q1	–	Sell	-152,949	Closed	-$28.1M	–	81
2025 Q4	$28.1M	Sell	152,949 -11,372	-7%	-$1.99M	3.64%	7
2025 Q3	$25.2M	Buy	164,321 +798	+0.5%	+$121K	3.28%	8
2025 Q2	$22.9M	Buy	163,523 +10,806	+7%	+$1.51M	3.1%	9
2025 Q1	$22.4M	Sell	152,717 -13,756	-8%	-$1.99M	3.14%	12
2024 Q4	$21.8M	Buy	166,473 +28,209	+20%	+$3.95M	3.01%	12
2024 Q3	$21.5M	Sell	138,264 -1,850	-1%	-$299K	2.83%	21
2024 Q2	$21.9M	Sell	140,114 -8,770	-6%	-$1.32M	2.98%	12
2024 Q1	$20.2M	Buy	+148,884	New	+$19.7M	2.74%	24

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

MIM

Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

Professional Advisory Services's AZN Position: Q2 2026 in Review

Professional Advisory Services opened a new position in AstraZeneca (AZN) in Q2 2026: 161,624 shares worth $30.2M. The stake represents 3.62% of the portfolio and ranks #7 among its holdings. This is a return to the name: Professional Advisory Services previously reported a position in AZN as recently as Q4 2025.

Professional Advisory Services first reported a position in AZN in Q1 2024 and has held it in 9 quarters since. 269 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Professional Advisory Services held 161,624 shares of AstraZeneca worth $30.2M as of Q2 2026.
AstraZeneca was a new Professional Advisory Services position in Q2 2026.
AstraZeneca made up 3.62% of Professional Advisory Services's portfolio in Q2 2026, its #7 holding.
Professional Advisory Services first reported a position in AstraZeneca in Q1 2024 and has held it in 9 quarters since.
269 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Professional Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.